Cold Chain Products Market

Cold Chain Products Market for Plasma Fractionation Size, Share & Trends by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027

Report Code: MD 8654 May, 2023, by marketsandmarkets.com

Cold Chain Products Market for Plasma Fractionation Size, Share & Trends

The size of global cold chain products market for plasma fractionation in terms of revenue was estimated to be worth $569 million in 2022 and is poised to reach $711 million by 2027, growing at a CAGR of 4.5% from 2022 to 2027. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

The market for cold chain products is expanding because of factors like rising zoonotic disease concerns, Rising use of immunoglobulins and other plasma products in a range of therapeutic area and Increasing demand for Plasma-derived medicinal products. The cold chain products industry is anticipated to develop because of the rising demand for plasma freezers and other cold chain products and the technology adoption by advanced cold storage devices. This is also going to attract international investors to that region.

Cold Chain Products Market for Plasma Fractionation Trends

Cold Chain Products Market

To know about the assumptions considered for the study, Request for Free Sample Report

Cold Chain Products Market

Cold Chain Products Market for Plasma Fractionation

Driver: Rising use of immunoglobulins and other plasma products in a range of therapeutic area

Immunoglobulins (IgG), also known as immune globulin or gamma globulin plays a crucial role in the treatment of primary immunodeficiency and various other conditions. Polyvalent immunoglobulins, prepared from multiple donors, are essential for addressing immunological disorders such as primary and secondary immunodeficiencies. Additionally, high-dose immunoglobulins exhibit immune-modulating effects in neurological, hematological, and dermatological immune diseases. Hyperimmune immunoglobulins with specific antibodies are utilized for preventing or treating infections like tetanus, measles, and rabies, as well as preventing hemolytic diseases in newborns. The demand for plasma fractionation is primarily driven by the clinical utilization of immunoglobulins, which has been steadily increasing and is expected to continue growing. This growing demand for plasma therapeutics, specifically immunoglobulins, in high-income countries can lead to the production of surplus amounts of other therapeutic proteins such as albumin. Consequently, the demand for cold chain products in the plasma fractionation market is projected to rise due to the increased usage of immunoglobulins and other plasma products, requiring storage equipment throughout the manufacturing and application process.

Opportunity: Demand for Plasma Fractionation Centre

The global demand for plasma-derived products is growing at a rate of approximately 7% per year due to increasing prevalence of diseases like hemophilia, immune deficiency disorders, and alpha-I antitrypsin deficiency. The United States, European Union, and China have the highest demand for these products, driven by the high prevalence of such diseases. Other regions, such as India and Africa, also require plasma fractionation centers. India's large population and high disease prevalence contribute to its demand for plasma-derived products, although the country relies on imports due to low plasma collection rates. Similarly, Africa faces limited availability of these products due to low plasma collection rates, often hindered by infrastructure and resource challenges.

Challenge: Shortage of trained manpower & limited resources to maintain the equipment

Plasma freezers and refrigerators play a critical role in storing temperature-sensitive plasma-based therapies. Maintaining the recommended storage temperature is crucial to preserve the quality and effectiveness of these therapies, which have a short shelf life. However, there is a growing concern about the shortage of skilled manpower and limited resources to maintain this vital storage equipment, particularly in developing countries. Insufficient infrastructure and lack of training among healthcare workers contribute to the risk of wastage and compromise patient care. The increased demand for convalescent plasma during the COVID-19 pandemic has further highlighted these challenges. It is imperative for healthcare facilities to prioritize cold chain management, invest in infrastructure, and provide proper training to ensure efficient storage and availability of plasma-based therapies while minimizing wastage.

Cold Chain Products Market for Plasma Fractionation Ecosystem

The ecosystem of the cold chain products industry for plasma fractionation is made up of the components that are present there and specifies these components with a list of the organizations involved. Manufacturers of different cold chain products include the businesses engaged in research, product development, optimization, and introduction of such goods. Distributors include third parties and e-commerce sites affiliated with the organization for selling these cold chain products, whereas end users are the areas where cold chain products are used.

Cold Chain Products Market Ecosystem

Temperature monitoring devices segment of Cold Chain Products Industry for Plasma Fractionation is expected to witness the fastest growth in the forecast period.

The cold chain products market for plasma fractionation is divided into seven types such as Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others. The market category for Temperature monitoring devices is anticipated to grow at the fastest rate between 2022 and 2027. The rising R&D investment on medical devices like medical freezers and refrigerators are additional factors that are expected to boost market expansion throughout the projected period.

Blood collection centers and blood component providers accounted for the largest share of the Cold Chain Products Industry for Plasma Fractionation.

The cold chain products market for plasma fractionation is divided into Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others based on end users. In 2021, The fastest growing market for Cold Chain Products for Plasma Fractionation, was held by Blood collection centers and blood component providers for cold chain products for plasma fractionation. Rising prevalence of diseases like hemophilia, immune deficiency disorders, and liver diseases, increasing aging population are all factors that contribute to the big proportion of this market.

North America accounted for the largest share of the Cold Chain Products Industry for Plasma Fractionation

The cold chain products market for plasma fractionation is divided into five regions based on geography: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the greatest market share for Cold Chain Products for Plasma Fractionation worldwide. It is anticipated that a major driver impacting the North America market growth would be the rising demand for plasma freezers, and the availability of advanced cold storage devices for labs.

The significant market share of North America is related to the presence of good healthcare infrastructure, as well as the rising R&D investment on medical devices like medical freezers and refrigerators.

Cold Chain Products Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the Cold Chain Products Market for Plasma Fractionation are B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)

Scope of the Cold Chain Products Industry

Report Metric

Details

Market Revenue Size in 2022

$569 million

Projected Revenue Size by 2027

$711 million

Industry Growth Rate

Poised to Grow at a CAGR of 4.5%

Market Driver

Rising use of immunoglobulins and other plasma products in a range of therapeutic area

Market Opportunity

Demand for Plasma Fractionation Centre

The research report categorizes Cold Chain Products Market for Plasma Fractionation to forecast revenue and analyze trends in each of the following submarkets:

By Type
  • Ultra-low temperature freezer
  • Plasma freezer
  • Temperature monitoring devices
  • Plasma contact shock freezer
  • Blood transport boxes
  • Ice-lined refrigerator
  • Others
By End User
  • Blood collection centers and blood component providers
  • Hospitals and transfusion centers
  • Clinical research laboratories
  • Others
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Australia
    • Japan
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • Turkey
    • Rest of MEA

Recent Developments of Cold Chain Products Industry for Plasma Fractionation

  • In January 2023, Haier Biomedical (China) acquired Suzhou Kangsheng (China) to incorporate disposable laboratory plastic consumables into its business portfolio and expand smart laboratory application solution scenarios and rapidly expanding its presence into the field of cryopreserving, cell culture, and microbial applications
  • In March 2023, Blue Star launched a range of deep freezers with extra storage and higher cooling capacity, manufactured at its new world-class manufacturing facility at Wada.
  • In March 2022, B Medical’s Ultra-Low Freezer U201 received the WHO PQS prequalification. This is the first-ever Ultra-Low Freezer in the world to receive the WHO PQS prequalification.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 22)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
          FIGURE 1 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION
          FIGURE 2 MARKET FOR PLASMA FRACTIONATION, BY REGION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 STAKEHOLDERS 
 
2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH APPROACH 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US)
          FIGURE 8 SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION (2021)
          FIGURE 9 MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH
          FIGURE 10 DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR
          FIGURE 11 CAGR PROJECTIONS
          FIGURE 12 TOP-DOWN APPROACH
    2.3 LIMITATIONS 
           2.3.1 METHODOLOGY-RELATED LIMITATIONS
           2.3.2 MARKET BREAKDOWN & DATA TRIANGULATION
                    FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
    2.7 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 39)
    FIGURE 14 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 42)
    4.1 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW 
          FIGURE 17 RISING USE OF IMMUNOGLOBULINS AND OTHER PLASMA PRODUCTS TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021) 
          FIGURE 18 ULTRA-LOW-TEMPERATURE FREEZERS TO HOLD LARGEST MARKET SHARE
    4.3 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
    4.4 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX 
          FIGURE 20 NORTH AMERICA TO DOMINATE MARKET OVER FORECAST PERIOD
    4.5 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES 
          FIGURE 21 DEVELOPING COUNTRIES TO PRESENT GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 46)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising use of immunoglobulins and other plasma products
                                FIGURE 23 WORLDWIDE POLYVALENT IMMUNE GLOBULIN SALES FROM 2010 TO 2026
                    5.2.1.2 Increasing demand for plasma-derived medicinal products to treat chronic diseases
                                TABLE 1 PLASMA-DERIVED MEDICINAL PRODUCTS AND THEIR CLINICAL INDICATIONS
                    5.2.1.3 Technological advancements in refrigeration equipment and systems
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Demand for plasma fractionation centers
                                FIGURE 24 PLASMA FRACTIONATION PLANTS WORLDWIDE (2018)
                    5.2.2.2 Government support for cold chain infrastructure development
           5.2.3 CHALLENGES
                    5.2.3.1 Shortage of trained manpower and limited resources to maintain equipment
                    5.2.3.2 Stringent government regulations
                    5.2.3.3 Environmental concerns regarding greenhouse gas emissions
    5.3 PRICING ANALYSIS 
           5.3.1 AVERAGE SELLING PRICE OF MARKET FOR PLASMA FRACTIONATION, BY TYPE
                    TABLE 2 AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS, BY TYPE (USD)
           5.3.2 AVERAGE SELLING PRICE TRENDS
    5.4 SUPPLY CHAIN ANALYSIS 
          FIGURE 25 SUPPLY CHAIN ANALYSIS: MARKET FOR PLASMA FRACTIONATION
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 26 ECOSYSTEM ANALYSIS: MARKET FOR PLASMA FRACTIONATION
    5.6 PATENT ANALYSIS 
          FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023)
          FIGURE 28 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION PATENTS (2013–2023)
    5.7 VALUE CHAIN ANALYSIS 
          FIGURE 29 VALUE CHAIN ANALYSIS: MARKET FOR PLASMA FRACTIONATION
    5.8 TECHNOLOGY ANALYSIS 
           5.8.1 KEY TECHNOLOGY
                    5.8.1.1 Ultra-low freezer technology
           5.8.2 ADJACENT TECHNOLOGY
                    5.8.2.1 Cryopreservation
    5.9 REGULATORY LANDSCAPE 
           5.9.1 REGULATORY ANALYSIS
                    5.9.1.1 North America
                    5.9.1.2 Europe
                    5.9.1.3 Asia Pacific
                    5.9.1.4 Latin America
                    5.9.1.5 Middle East and Africa
           5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATION
                    TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 ASIA PACIFIC AND ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.10 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 6 PORTER’S FIVE FORCES ANALYSIS: MARKET FOR PLASMA FRACTIONATION
           5.10.1 INTENSITY OF COMPETITIVE RIVALRY
           5.10.2 BARGAINING POWER OF SUPPLIERS
           5.10.3 BARGAINING POWER OF BUYERS
           5.10.4 THREAT OF NEW ENTRANTS
           5.10.5 THREAT OF SUBSTITUTES
    5.11 KEY CONFERENCES AND EVENTS, 2023–2024 
           TABLE 7 MARKET FOR PLASMA FRACTIONATION: KEY CONFERENCES AND EVENTS, 2023–2024
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION
                     TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF MARKET FOR PLASMA FRACTIONATION
           5.12.2 BUYING CRITERIA
                     TABLE 9 KEY BUYING CRITERIA FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION
    5.13 TRADE ANALYSIS 
           TABLE 10 EXPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)
           TABLE 11 IMPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)
    5.14 MARKET FOR PLASMA FRACTIONATION: RECESSION IMPACT 
 
6 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE (Page No. - 70)
    6.1 INTRODUCTION 
          TABLE 12 COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 13 COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
    6.2 ULTRA-LOW-TEMPERATURE FREEZERS 
           6.2.1 RISING DEMAND IN PLASMA STORAGE APPLICATIONS TO DRIVE MARKET GROWTH
                    TABLE 14 ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 PLASMA FREEZERS 
           6.3.1 RISING DEMAND IN SCIENTIFIC AND THERAPEUTIC APPLICATIONS TO BOOST GROWTH
                    TABLE 15 PLASMA FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 TEMPERATURE MONITORING DEVICES 
           6.4.1 ADOPTION OF NOVEL TECHNOLOGIES IN TEMPERATURE MONITORING DEVICES TO PROPEL MARKET
                    TABLE 16 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 PLASMA CONTACT SHOCK FREEZERS 
           6.5.1 NEED FOR RAPID FREEZING IN PLASMA TRANSPORT TO DRIVE MARKET
                    TABLE 17 PLASMA CONTACT SHOCK FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 BLOOD TRANSPORT BOXES 
           6.6.1 RISING ADOPTION OF TEMPERATURE-CONTROLLED BOXES TO TRANSPORT PLASMA FRACTIONATED COMPOUNDS TO DRIVE MARKET
                    TABLE 18 BLOOD TRANSPORT BOXES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.7 ICE-LINED REFRIGERATORS 
           6.7.1 COST-EFFECTIVENESS TO PROPEL END-USER ADOPTION
                    TABLE 19 ICE-LINED REFRIGERATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.8 OTHER PRODUCTS 
          TABLE 20 OTHER COLD CHAIN PRODUCTS INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER (Page No. - 81)
    7.1 INTRODUCTION 
          TABLE 21 COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
    7.2 BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS 
           7.2.1 RISING DEMAND FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH
                    TABLE 22 MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 HOSPITALS & TRANSFUSION CENTERS 
           7.3.1 NEED TO ENSURE SAFE COLLECTION, STORAGE, AND COLD CHAIN MANAGEMENT OF PLASMA TO DRIVE MARKET GROWTH
                    TABLE 23 MARKET FOR HOSPITALS & TRANSFUSION CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 CLINICAL RESEARCH LABORATORIES 
           7.4.1 ROLE OF LABS IN PLASMA FRACTIONATION AND COLD CHAIN PRODUCT DEVELOPMENT TO BOOST MARKET GROWTH
                    TABLE 24 MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 OTHER END USERS 
          TABLE 25 MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
 
8 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION (Page No. - 87)
    8.1 INTRODUCTION 
          FIGURE 31 COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES
          TABLE 26 MARKET FOR PLASMA FRACTIONATION, BY REGION, 2020–2027 (USD MILLION)
    8.2 NORTH AMERICA 
           8.2.1 NORTH AMERICA: RECESSION IMPACT
                    FIGURE 32 NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT
                    TABLE 27 NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 28 NORTH AMERICA: MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 29 NORTH AMERICA: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.2.2 US
                    8.2.2.1 US to hold largest share of North American market
                                 TABLE 30 US: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 31 US: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.2.3 CANADA
                    8.2.3.1 Growing pharma R&D and increasing use of plasma-derived compounds to boost market
                                 TABLE 32 CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 33 CANADA: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
    8.3 EUROPE 
           8.3.1 EUROPE: RECESSION IMPACT
                    TABLE 34 EUROPE: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 35 EUROPE: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 36 EUROPE: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.3.2 GERMANY
                    8.3.2.1 Germany to dominate European market
                                 TABLE 37 GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 38 GERMANY: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.3.3 FRANCE
                    8.3.3.1 Growing biotech & pharma industry and high prevalence of bleeding disorders to drive market
                                 TABLE 39 FRANCE: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 40 FRANCE: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.3.4 UK
                    8.3.4.1 Rising incidence of hemophilia and growing consumption of coagulation factors to propel market
                                 TABLE 41 UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 42 UK: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.3.5 ITALY
                    8.3.5.1 Strong pharma sector and rising geriatric population to support market
                                 TABLE 43 ITALY: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 44 ITALY: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.3.6 SPAIN
                    8.3.6.1 Rising chronic disease prevalence to boost demand
                                 TABLE 45 SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 46 SPAIN: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.3.7 REST OF EUROPE
                    TABLE 47 REST OF EUROPE: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 48 REST OF EUROPE: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
    8.4 ASIA PACIFIC 
           8.4.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 33 APAC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SNAPSHOT
                    TABLE 49 ASIA PACIFIC: MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 50 ASIA PACIFIC: MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 51 ASIA PACIFIC: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.4.2 CHINA
                    8.4.2.1 China to dominate Asia Pacific market
                                 TABLE 52 CHINA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 53 CHINA: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.4.3 JAPAN
                    8.4.3.1 Growing aging population and rising prevalence of neurological disorders to propel growth
                                 TABLE 54 JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 55 JAPAN: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.4.4 INDIA
                    8.4.4.1 Growing pharma-biotech industry to drive demand
                                 TABLE 56 INDIA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 57 INDIA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.4.5 SOUTH KOREA
                    8.4.5.1 Rising awareness, advancements in medical treatments, and aging population to drive market
                                 TABLE 58 SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 59 SOUTH KOREA: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.4.6 AUSTRALIA
                    8.4.6.1 Rising demand for plasma products to treat chronic diseases to propel market
                                 TABLE 60 AUSTRALIA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                                 TABLE 61 AUSTRALIA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
           8.4.7 REST OF ASIA PACIFIC
                    TABLE 62 REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 63 REST OF ASIA PACIFIC: MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
    8.5 LATIN AMERICA 
           8.5.1 RISING INVESTMENTS IN BRAZIL AND GROWING DISEASE PREVALENCE ACROSS LATAM TO BOOST MARKET
           8.5.2 LATIN AMERICA: RECESSION IMPACT
                    TABLE 64 LATIN AMERICA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 65 LATIN AMERICA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
    8.6 MIDDLE EAST & AFRICA 
           8.6.1 INFRASTRUCTURAL DEVELOPMENT IN HEALTHCARE TO OFFER GROWTH OPPORTUNITIES
           8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 66 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 67 MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS INDUSTRY FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)
 
9 COMPETITIVE LANDSCAPE (Page No. - 122)
    9.1 OVERVIEW 
    9.2 KEY PLAYER STRATEGIES 
          TABLE 68 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION
    9.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN MARKET FOR PLASMA FRACTIONATION 
          FIGURE 34 REVENUE ANALYSIS FOR KEY PLAYERS IN MARKET FOR PLASMA FRACTIONATION MARKET
    9.4 MARKET SHARE ANALYSIS 
          FIGURE 35 COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
          TABLE 69 MARKET FOR PLASMA FRACTIONATION: DEGREE OF COMPETITION
          FIGURE 36 R&D ASSESSMENT OF KEY PLAYERS
    9.5 COMPANY EVALUATION QUADRANT (KEY COMPANIES), 2021 
           9.5.1 STARS
           9.5.2 PERVASIVE PLAYERS
           9.5.3 EMERGING LEADERS
           9.5.4 PARTICIPANTS
                    FIGURE 37 COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: COMPANY EVALUATION MATRIX, 2021
    9.6 COMPETITIVE BENCHMARKING 
          TABLE 70 OVERALL COMPANY FOOTPRINT
          TABLE 71 COMPANY FOOTPRINT ANALYSIS, BY TYPE
          TABLE 72 COMPANY FOOTPRINT ANALYSIS, BY END USER
          TABLE 73 COMPANY FOOTPRINT ANALYSIS, BY REGION
    9.7 COMPETITIVE SCENARIO 
           9.7.1 PRODUCT LAUNCHES & APPROVALS
                    TABLE 74 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MARCH 2023
           9.7.2 DEALS
                    TABLE 75 DEALS, JANUARY 2021–MARCH 2023
           9.7.3 OTHER DEVELOPMENTS
                    TABLE 76 OTHER DEVELOPMENTS, JANUARY 2019– MARCH 2023
 
10 COMPANY PROFILES (Page No. - 135)
(Business overview, Products offered, Recent Developments, MNM view)*
     10.1 KEY PLAYERS 
             10.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 77 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
             10.1.2 HAIER BIOMEDICAL (HAIER GROUP)
                        TABLE 78 HAIER BIOMEDICAL: BUSINESS OVERVIEW
                        FIGURE 39 HAIER BIOMEDICAL (HAIER GROUP): COMPANY SNAPSHOT (2021)
             10.1.3 EPPENDORF SE
                        TABLE 79 EPPENDORF AG: BUSINESS OVERVIEW
                        FIGURE 40 EPPENDORF AG: COMPANY SNAPSHOT
             10.1.4 B MEDICAL SYSTEMS (AZENTA)
                        TABLE 80 B. MEDICAL SYSTEM (AZENTA): BUSINESS OVERVIEW
                        FIGURE 41 B MEDICAL SYSTEMS (AZENTA): COMPANY SNAPSHOT (2021)
             10.1.5 BLUE STAR LIMITED
                        TABLE 81 BLUE STAR LIMITED: BUSINESS OVERVIEW
                        FIGURE 42 BLUE STAR LIMITED: COMPANY SNAPSHOT
                        TABLE 82 BLUE STAR LIMITED: PRODUCTS OFFERED
             10.1.6 AVANTOR, INC.
                        TABLE 83 AVANTOR, INC.: BUSINESS OVERVIEW
                        FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT
             10.1.7 GODREJ AND BOYCE MANUFACTURING CO. LTD.
                        TABLE 84 GODREJ AND BOYCE MANUFACTURING CO. LTD.: BUSINESS OVERVIEW
                        FIGURE 44 GODREJ AND BOYCE MANUFACTURING CO. LTD.: COMPANY SNAPSHOT
             10.1.8 BIOLIFE SOLUTIONS
                        TABLE 85 BIOLIFE SOLUTIONS: BUSINESS OVERVIEW
                        FIGURE 45 BIOLIFE SOLUTIONS: COMPANY SNAPSHOT
             10.1.9 HELMER SCIENTIFIC
                        TABLE 86 HELMER SCIENTIFIC: BUSINESS OVERVIEW
             10.1.10 VESTFROST SOLUTIONS A/S
                        TABLE 87 VESTFROST SOLUTIONS A/S: BUSINESS OVERVIEW
             10.1.11 JEIO TECH INC.
                        TABLE 88 JEIO TECH INC.: BUSINESS OVERVIEW
             10.1.12 DEEPEE COOLING PRODUCTS
                        TABLE 89 DEEPEE COOLING PRODUCTS: BUSINESS OVERVIEW
             10.1.13 BERLINGER & CO. AG
                        TABLE 90 BERLINGER & CO. AG: BUSINESS OVERVIEW
             10.1.14 MONNIT CORPORATION
                        TABLE 91 MONNIT CORPORATION: BUSINESS OVERVIEW
             10.1.15 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.
                        TABLE 92 ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
     10.2 OTHER PLAYERS 
             10.2.1 QINGDAO CAREBIOS BIOLOGICAL TECHNOLOGY CO., LTD
             10.2.2 EBAC CO., LTD.
             10.2.3 BIOTECNO
             10.2.4 ZHONGKE MEILING CRYOGENICS CO., LTD.
             10.2.5 BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
             10.2.6 STERICOX INDIA PRIVATE LIMITED
             10.2.7 ENVIRO TECHNOLOGIES
             10.2.8 WITHNELL SENSORS
             10.2.9 TECNOSOFT SRL
             10.2.10 PHILIPP KIRSCH GMBH
 
11 APPENDIX (Page No. - 183)
     11.1 DISCUSSION GUIDE 
     11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     11.3 RELATED REPORTS 
     11.4 AUTHOR DETAILS 

The market size for Cold Chain Products for Plasma Fractionation was estimated using four main methods in this study. The market, as well as its peer and parent markets, were the subject of extensive research. The subsequent phase involved doing primary research to confirm these conclusions, presumptions, and estimates with industry professionals across the value chain. For estimating the value market, top-down and bottom-up strategies were both used. The market size of segments and subsegments was then estimated using market breakdown and data triangulation processes.

Secondary Research

There were several secondary sources used in this study, including directories, databases like Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, corporate house documents, investor presentations, and firm SEC filings. To find and gather data for the detailed, technical, market-focused, and commercial analysis of the Cold Chain Products Market for Plasma Fractionation, secondary research was carried out. Relevant information on major companies, market classification and segmentation according to industry trends down to the most basic level, and significant changes regarding market and technological views were also obtained. Additionally, utilizing secondary research, a database of the important industry executives was created.

Primary Research

To gather qualitative and quantitative data for this study, a variety of sources from the supply and demand sides were interviewed during the main research phase. CEOs, vice presidents, marketing and sales directors, business development managers, technology, and innovation directors of Cold Chain Products for Plasma Fractionation manufacturing businesses, key opinion leaders, suppliers, and distributors are the main sources on the supply side. Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others are some of the main demand-side suppliers.

The breakup of primary research:

Supply Side

Cold Chain Products Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for Cold Chain Products for Plasma Fractionation was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for Cold Chain Products for Plasma Fractionation was calculated using data from four distinct sources, as will be discussed below:

Cold Chain Products for Plasma Fractionation: Country-level Analysis- Bottoms up approach

Cold Chain Products Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Cold Chain Products for Plasma Fractionation: Top-Down approach

Cold Chain Products Market Size, and Share

Cold Chain Products for Plasma Fractionation: Revenue Share Analysis

Cold Chain Products Market Size, and Share

Cold Chain Products for Plasma Fractionation: Country level Analysis

Cold Chain Products Market Size, and Share

Data Triangulation

The entire market was split up into several segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.

Approach to derive the market size and estimate market growth

Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of cold chain products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market definition

Blood products include whole blood and blood components namely cellular components, plasma, cryoprecipitate, and Plasma-derived medicinal products (PDMPs), which are purified plasma protein concentrates that undergo pathogen reduction procedures that are manufactured from pools of thousands of plasma units by an industrial process called plasma fractionation. The equipment that is needed for storage and transport of these plasma fractionated compounds in temperature-controlled environments is usually called cold chain products or equipment.

Key Stakeholders

  • Cold chain equipment Manufacturers
  • Cold chain equipment Distributors
  • Medical device R&D Companies
  • Clinics and Hospitals
  • Plasma Research Institutes and Universities
  • Venture Capitalists and Investors
  • Market Research and Consulting Firms
  • Government Associations

Objectives of the Study

  • To define, describe, segment, and forecast the Cold Chain Products Market for Plasma Fractionation based on type, end user, and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).
  • To assess the market regarding Porter’s five forces analysis, regulatory landscape, value chain, supply chain, ecosystem analysis, patent analysis, and the impact of the economic recession.
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.
  • To forecast the size of the market in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape.
  • To profile the key players in the market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as product launches and approvals, acquisitions, expansions, partnerships, and agreements in the market.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 8654
Published ON
May, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cold Chain Products Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback